Search results
3 Reasons CDs Aren't Worth Buying, Even With Rates Above 5.00%
The Motley Fool via AOL· 50 minutes agoThat's a pretty specific timeline, and not many people find themselves in that situation very often....
Phillies rally late for 4-3 win over Padres
The News-Times· 4 hours agoNick Castellanos hit a bloop ground-rule double down the right field line to cap four consecutive ninth-inning hits and the Philadelphia Phillies rallied...
Tropical system brings heavy rain, flood threat to Corpus Christi, south Texas
Corpus Christi Caller-Times via Yahoo News· 54 minutes agoAlso closing is the gate to the Packery Channel Jetty walkway, where “conditions are deteriorating,”...
At least 1 reported dead in New Mexico as 2 wildfires burn near communities, officials say
CNN via AOL· 3 hours ago“There is potential with this wind coming in from the west to have additional homes impacted.” ...
Royal Ascot tips today: Best selections for Wednesday and race-by-race results
The Telegraph via Yahoo Sports· 1 hour agoHandling the quick conditions here is likely to be an important factor and one who should cope with...
The Nasdaq Is Soaring, but These 3 Stocks Are Near Their 52-Week Lows
Motley Fool via Yahoo Finance· 17 minutes agoKeeping costs down will remain a priority for businesses until borrowing conditions improve. For the...
Anil Kapoor REVEALED the Reason for Hosting Bigg Boss OTT 3 | Anil Kapoor interview | Salman Khan
Fox Bangor· 2 hours agoAnil Kapoor Interview: Bigg Boss OTT 3 is the third season, and from the house to the contestants...
Symptoms of the KP.3 COVID Variant, the New Dominant Strain
Prevention via Yahoo News· 21 hours agoHow can you prevent a KP.3 infection? To lower your risk of getting a KP.3 infection, Dr. Schaffner...
3 UK Growth Companies With Up To 24% Insider Ownership
Simply Wall St. via Yahoo Finance· 3 hours agoAs the UK market braces for key economic updates, including inflation data and the Bank of England's...
New JAK 1 Inhibitor Proves Promising in Phase 3 RA Trial
Medscape· 5 hours ago"This is the first highly selective JAK inhibitor originally developed, and a phase 3 clinical trial...